Elevated plasma homocysteine concentrations in severe preeclampsia and eclampsia

Area of Science:

• Obstetrics and Gynecology
• Clinical Biochemistry
• Maternal-Fetal Medicine

Background:

• Homocysteine is an amino acid vital for human cell and tissue growth.
• Elevated maternal homocysteine (hyperhomocysteinemia) is associated with placenta-mediated pregnancy complications, including preeclampsia.
• Understanding homocysteine levels in relation to preeclampsia severity is crucial for maternal health.

Purpose of the Study:

• To investigate plasma homocysteine levels in pregnant women.
• To determine the association between homocysteine concentration and the severity of preeclampsia.

Main Methods:

• A case-control study involving 32 mild preeclamptic, 25 severe preeclamptic, 16 eclamptic patients, and 34 healthy controls.
• Maternal plasma homocysteine was quantified using high-performance liquid chromatography during the antenatal period.
• Demographic data were analyzed to ensure comparability between groups.

Main Results:

• Plasma homocysteine levels were significantly elevated in women with severe preeclampsia (16.7 ± 10.1 µmol/L) and eclampsia (16.5 ± 9.6 µmol/L) compared to mild preeclampsia (7.7 ± 2.4 µmol/L) and controls (6.7 ± 1.6 µmol/L) (p < 0.0001).
• No significant difference in homocysteine levels was observed between mild preeclampsia and the control group.
• Demographic characteristics showed no significant variations across the study groups.

Conclusions:

• Plasma homocysteine concentrations are significantly increased in severe preeclampsia and eclampsia.
• Mild preeclampsia does not show a significant elevation in plasma homocysteine levels compared to controls.
• Elevated homocysteine may serve as a biomarker for the severity of preeclampsia.